stent-403500-edited.png

“I think it will help you as a doctor to know you’re doing a treatment not only for 3 months, but that the treatment benefit is going to last for at least 2 years,” said Yvo Roos, MD. “It’s going to help you be more convincing to the relatives that you’re doing the right thing, that you’re doing something that’s really going to help them."

The above quote is in reference to new long-term followup data published as of April 6th, 2017, which now confirms and extends the outcomes of the MR CLEAN endovascular therapy trial in acute ischemic stroke patients.  The results show that 1 out of every 3 patients treated with catheter based intervention are returning home to care for themselves within 3 months and these results are durable up to 2 years! Read the full details of the follow up data right here

LEARN ABOUT PULSARA

Brittney Nelson, BSN, RN, SCRN

Written by Brittney Nelson, BSN, RN, SCRN

Brittney is a registered nurse and SCRN who served as the Stroke Coordinator at Trinity Mother Frances Hospital. Her passion for stroke patients and the acute stroke care process led her to her current position as Implementation Specialist at Pulsara.